http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2185859-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0caa75f486b084b8286ccb04dbaf8e8c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
filingDate 1996-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ed8a2fc99559cf2b97e77fb043b80f5
publicationDate 2011-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2185859-C
titleOfInvention Preparation of virally inactivated intravenously injectable immune serum globulin
abstract Method of reducing the anticomplement activity (ACA) resulting from viral inactivation treatment of a solution of antibodies, the method comprising contacting the solution with a trialkylphosphate, such as tri-n-butyl phosphate, and a detergent, such as sodium cholate, under conditions sufficient to reduce substantially the virus activity, and then incubating the solution under controlled conditions of time, pH, temperature, and ionic strength such that the anticomplement activity is reduced to an acceptable level. In a preferred embodiment, the ACA is reduced to less than 60 CH50 units/mL, the incubation is for at least about ten days at a pH from 3.5 to 5.0, the temperature is maintained within a range of 2 to 50° C, and the ionic strength of the solution is less than about 0.001.
priorityDate 1995-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9RF12
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09598
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2UCT7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5MBK3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668194
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP59026
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA2QW65
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524917
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451265449
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ46150
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6CZT2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02158
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C1C2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8VUZ6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487501
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C1C3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ0TV31
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP20419
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5BEB9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31357
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP98160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453

Total number of triples: 49.